tga bpc-157 approval status australia Peptides Are Now on the TGA's Radar. Is Your Clinic Ready? BPC-157 10mg – Research Peptide

It covers more pathways than CagriSema (which is missing GIP) but fewer than cag + retatrutide (which adds glucagon)

Our small intestines naturally produce the GLP-1 hormone, which does exactly what the synthetic medication does: Slows digestion Reduces hunger Increases feelings of fullness Enhances insulin sensitivity Manages blood sugar levels Decreases food chatter and food noise The problem is that, for many of us, our GLP-1 hormone no longer functions optimally

This is another area of active debate

For instance, pairing a peptide that activates glutathione-associated pathways with one that stabilizes mitochondrial membranes can both reduce ROS generation and accelerate repair